Gilder Gagnon Howe & CO LLC Glaukos Corp Transaction History
Gilder Gagnon Howe & CO LLC
- $8.56 Billion
- Q4 2024
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Glaukos Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 825,276 shares of GKOS stock, worth $99.5 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
825,276
Previous 658,599
25.31%
Holding current value
$99.5 Million
Previous $85.8 Million
44.22%
% of portfolio
1.45%
Previous 1.09%
Shares
27 transactions
Others Institutions Holding GKOS
# of Institutions
354Shares Held
50MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$969 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$720 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$260 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$249 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$233 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.74B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...